EP Patent

EP0998944A2 — Enteric coated formulation of a benzimidazole derivative and method for preparation thereof

Assigned to Hanmi Pharmaceutical Co Ltd · Expires 2000-05-10 · 26y expired

What this patent protects

Disclosed are an enteric coated formulation of a benzimidazole derivative comprising a core and a film of an enteric coating agent on the surface thereof, the core containing a complex of the benzimidazole derivative and an ion-exchange resin, and the enteric coating agent having…

USPTO Abstract

Disclosed are an enteric coated formulation of a benzimidazole derivative comprising a core and a film of an enteric coating agent on the surface thereof, the core containing a complex of the benzimidazole derivative and an ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%, and a method for preparation thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0998944A2
Jurisdiction
EP
Classification
—
Expires
2000-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Hanmi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.